1. LC3C Contributes to Vpu-Mediated Antagonism of BST2/Tetherin Restriction on HIV-1 Release through a Non-canonical Autophagy Pathway
- Author
-
Stéphane Frémont, Aurelia Kuster, Olivier Leymarie, Ursula Madjo, Katy Janvier, Sarah Gallois-Montbrun, Clarisse Berlioz-Torrent, Mélanie Nehlich, Institut Cochin (IC UM3 (UMR 8104 / U1016)), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), U.M. holds a fellowship from the 'Ministère français de l’enseignement supérieur et de la Recherche' and then from SIDACTION. O.L. holds a fellowship from SIDACTION and then from ANRS, S.F. holds a fellowship from the 'Fondation pour la recherche médicale,' and A.K. holds a fellowship from ANRS. This work is funded by ANRS., and We thank Patrice Codogno, Stéphane Emiliani, Monica Naughtin, and Florence Margottin-Goguet for helpful discussions and Annegret Pelchen-Mathews for IEM images. We thank the Imaging Facility and the Immunobiology Facility of the Cochin Institute for technical assistance. The following reagents were obtained through the NIBCS: HIV-1 gp120 monoclonal antibody (2G12) from Dr. H. Katinger, mouse antibodies against CAp24 (38:96K and EF7, EVA365, and 366, respectively) from B. Wahren and p17 (4C9, ARP342) from R.B. Ferns and R.S. Tedder. The following reagents were obtained through the NIH AIDS reagent program: anti-human BST2 from Drs. K. Strebel and A. Andrew, HIV-1 NL4-3 Vpu antiserum from Drs. K. Strebel and F. Maldarelli, and pNL4-3 from Dr. M. Martin. We thank Dr. K. Strebel for the gift of pNL4-3/Udel proviral DNA, Dr. T. Johansen for the human ATG8 ortholog cDNA, Dr. M. Faure for pCI-3xFlag-p62 and pCR3-3xFlag-NDP52, and Dr. P.D. Bieniasz for pNL4-3(MA/YFP) proviral DNA.
- Subjects
0301 basic medicine ,MESH: Human Immunodeficiency Virus Proteins/metabolism ,[SDV]Life Sciences [q-bio] ,LC3C ,animal diseases ,viruses ,Human Immunodeficiency Virus Proteins ,Autophagy-Related Proteins ,restriction ,MESH: Amino Acid Sequence ,MESH: Virus Release ,MESH: Human Immunodeficiency Virus Proteins/chemistry ,Viral Regulatory and Accessory Proteins ,Virus Release ,Budding ,virus diseases ,tetherin ,LC3-associated phagocytosis ,3. Good health ,Cell biology ,[SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitology ,MESH: HEK293 Cells ,ATG5 ,Microtubule-Associated Proteins ,Protein Binding ,autophagy ,ATG8 ,Phagocytosis ,MESH: Viral Regulatory and Accessory Proteins/metabolism ,BST2 ,Biology ,GPI-Linked Proteins ,MESH: Antigens, CD/metabolism ,General Biochemistry, Genetics and Molecular Biology ,03 medical and health sciences ,Viral envelope ,Antigens, CD ,Vpu ,Humans ,MESH: Protein Binding ,[SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology ,Amino Acid Sequence ,MESH: GPI-Linked Proteins/metabolism ,MESH: Autophagy ,MESH: Autophagy-Related Proteins/metabolism ,MESH: HIV-1/metabolism ,MESH: Humans ,Autophagy ,biochemical phenomena, metabolism, and nutrition ,Virology ,ATG ,MESH: Viral Regulatory and Accessory Proteins/chemistry ,HEK293 Cells ,030104 developmental biology ,MESH: HeLa Cells ,HIV-1 ,Tetherin ,MESH: Microtubule-Associated Proteins/metabolism ,Antagonism ,HeLa Cells - Abstract
International audience; BST2 (bone marrow stromal antigen 2)/tetherin is a restriction factor of enveloped viruses, which blocks the release of viral particles. HIV-1 encodes proteins that antagonize this innate barrier, including the accessory protein Vpu. Here, we investigate whether the autophagy pathway and/or ATG proteins are hijacked by HIV-1 Vpu to circumvent BST2 restriction of viral release. We report that BST2 and Vpu are present in LC3-positive compartments. We found that Vpu selectively interacts with the ATG8 ortholog LC3C through the Vpu L63VEM66 sequence. This sequence is required for Vpu to antagonize BST2 restriction. LC3C expression favors the removal of BST2 from the HIV-1 budding site, and thus HIV-1 release in BST2-expressing cells. Additionally, ATG5 and beclin 1/ATG6, but not all the components of the autophagy pathway, act with LC3C to facilitate Vpu antagonism of BST2 restriction. Altogether, our data support the view that a non-canonical autophagy pathway reminiscent of LC3-associated phagocytosis contributes to Vpu counteraction of BST2 restriction.
- Published
- 2016
- Full Text
- View/download PDF